Literature DB >> 29179176

Neurons, Erythrocytes and Beyond -The Diverse Functions of Chorein.

Florian Lang1,2, Lisann Pelzl3, Ludger Schöls4,5, Andreas Hermann6, Michael Föller7, Tilman E Schäffer8, Christos Stournaras9.   

Abstract

Chorea-acanthocytosis (ChAc), a neurodegenerative disease, results from loss-of-function-mutations of the chorein-encoding gene VPS13A. Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes. Those pathologies may be paralleled by erythrocyte acanthocytosis. Chorein supports activation of phosphoinositide-3-kinase (PI3K)-p85-subunit with subsequent up-regulation of ras-related C3 botulinum toxin substrate 1 (Rac1) activity, p21 protein-activated kinase 1 (PAK1) phosphorylation, and activation of several tyrosine kinases. Chorein sensitive PI3K signaling further leads to stimulation of the serum and glucocorticoid inducible kinase SGK1, which in turn upregulates ORAI1, a Ca2+-channel accomplishing store operated Ca2+-entry (SOCE). The signaling participates in the regulation of cytoskeletal architecture on the one side and cell survival on the other. Compromised cytoskeletal architecture has been shown in chorein deficient erythrocytes, fibroblasts and endothelial cells. Impaired degranulation was observed in chorein deficient PC12 cells and in platelets from ChAc patients. Similarly, decreased ORAI1 expression and SOCE as well as compromised cell survival were seen in fibroblasts and neurons isolated from ChAc patients. ORAI1 expression, SOCE and cell survival can be restored by lithium treatment, an effect disrupted by pharmacological inhibition of SGK1 or ORAI1. Chorein, SGK1, ORAI1 and SOCE further confer survival of tumor cells. In conclusion, much has been learned about the function of chorein and the molecular pathophysiology of chorea-acanthocytosis. Most importantly, a treatment halting or delaying the clinical course of this devastating disease may become available. A controlled clinical study is warranted, in order to explore whether the in vitro observations indeed reflect the in vivo pathology of the disease.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; Autophagy; Chorea-acanthocytosis; Cytoskeleton; Exocytosis; Lithium; Orai1; SGK1; Store operated Ca2+ entry

Mesh:

Substances:

Year:  2017        PMID: 29179176     DOI: 10.1159/000485457

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  8 in total

1.  A Case of Genetically Confirmed Chorea-Acanthocytosis: Brain [18F]FDG-PET and [18F]FP-CIT-PET Findings.

Authors:  Jong-Mok Lee; Chae Moon Hong; Ho-Sung Ryu
Journal:  Ann Indian Acad Neurol       Date:  2019-12-18       Impact factor: 1.383

2.  Decreased Na+/K+ ATPase Expression and Depolarized Cell Membrane in Neurons Differentiated from Chorea-Acanthocytosis Patients.

Authors:  Zohreh Hosseinzadeh; Stefan Hauser; Yogesh Singh; Lisann Pelzl; Stefanie Schuster; Yamini Sharma; Philip Höflinger; Nefeli Zacharopoulou; Christos Stournaras; Daniel L Rathbun; Eberhart Zrenner; Ludger Schöls; Florian Lang
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

3.  Smoking affects gene expression in blood of patients with ischemic stroke.

Authors:  Xiyuan Cheng; Eva Ferino; Heather Hull; Glen C Jickling; Bradley P Ander; Boryana Stamova; Frank R Sharp
Journal:  Ann Clin Transl Neurol       Date:  2019-08-22       Impact factor: 4.511

4.  Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease.

Authors:  Kamran Tariq; Bryan W Luikart
Journal:  Explor Neuroprotective Ther       Date:  2021-10-29

5.  Biological Function and Clinical Value of VPS13A in Pan-Cancer Based on Bioinformatics Analysis.

Authors:  Xue Qin Zhang; Li Li
Journal:  Int J Gen Med       Date:  2021-10-16

Review 6.  Eryptosis: Programmed Death of Nucleus-Free, Iron-Filled Blood Cells.

Authors:  Peter Dreischer; Michael Duszenko; Jasmin Stein; Thomas Wieder
Journal:  Cells       Date:  2022-02-01       Impact factor: 6.600

7.  Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.

Authors:  Kevin Peikert; Hannes Glaß; Enrica Federti; Alessandro Matte; Lisann Pelzl; Katja Akgün; Tjalf Ziemssen; Rainer Ordemann; Florian Lang; The Network For Translational Research For Neuroacanthocytosis Patients; Lucia De Franceschi; Andreas Hermann
Journal:  J Pers Med       Date:  2021-05-10

8.  Chorea-Acanthocytosis Presenting as Autosomal Recessive Epilepsy in a Family With a Novel VPS13A Mutation.

Authors:  Juliane Weber; Lars Frings; Michel Rijntjes; Horst Urbach; Judith Fischer; Cornelius Weiller; Philipp T Meyer; Stephan Klebe
Journal:  Front Neurol       Date:  2019-01-09       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.